VERA

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Vera Therapeutics Inc

NASDAQ | VERA

30.49

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 13, 2025)

$1.92B

Market Cap

-

P/E Ratio

-3.59

EPS

$51.61

52 Week High

$18.53

52 Week Low

HEALTHCARE

Sector

VERA Chart

Recent Chart
Price Action

VERA Technicals

Tags:

VERA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$167M
Selling General And Administrative $41M
Research And Development $126M
Operating Expenses $167M
Investment Income Net -
Net Interest Income $13M
Interest Income $21M
Interest Expense $7.6M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -$7.4M
Income Before Tax -$152M
Income Tax Expense $1K
Interest And Debt Expense -
Net Income From Continuing Operations -$152M
Comprehensive Income Net Of Tax -
Ebit -$160M
Ebitda -$167M
Net Income -$152M

Revenue & Profitability

Earnings Performance

VERA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $656M
Total Current Assets $651M
Cash And Cash Equivalents At Carrying Value $93M
Cash And Short Term Investments $93M
Inventory -
Current Net Receivables $3.8M
Total Non Current Assets $4.5M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $548M
Other Current Assets $6.6M
Other Non Current Assets -
Total Liabilities $79M
Total Current Liabilities $25M
Current Accounts Payable $7.7M
Deferred Revenue -
Current Debt -
Short Term Debt $1.5M
Total Non Current Liabilities $53M
Capital Lease Obligations $4M
Long Term Debt $51M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $55M
Other Current Liabilities $16M
Other Non Current Liabilities -
Total Shareholder Equity $577M
Treasury Stock -
Retained Earnings -$461M
Common Stock $64K
Common Stock Shares Outstanding $55M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$135M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $105K
Capital Expenditures $972K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$425M
Cashflow From Financing $607M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$13K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$152M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$167M
Selling General And Administrative $41M
Research And Development $126M
Operating Expenses $167M
Investment Income Net -
Net Interest Income $13M
Interest Income $21M
Interest Expense $7.6M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -$7.4M
Income Before Tax -$152M
Income Tax Expense $1K
Interest And Debt Expense -
Net Income From Continuing Operations -$152M
Comprehensive Income Net Of Tax -
Ebit -$160M
Ebitda -$167M
Net Income -$152M

VERA News

VERA Profile

Vera Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Vera Therapeutics Inc. is a clinical-stage biotechnology company headquartered in South San Francisco, California, dedicated to the development and commercialization of innovative therapies for serious immune-mediated diseases. With a strong focus on addressing unmet medical needs, Vera is advancing a robust pipeline aimed at improving the quality of life for patients in the United States. The company is poised to make significant contributions to the field of immunology through its novel therapeutic approaches.

VHAI
-25.00%
$0.00
YYAI
-12.69%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+6.25%
$0.50
PLUG
+13.30%
$3.87
ELBM
+334.95%
$7.17
GWH
+118.14%
$9.07
BITF
+28.33%
$5.39
RGTI
+20.26%
$52.82
NVDA
+2.98%
$188.62
ASST
-35.33%
$1.00
BYND
-48.50%
$1.03
IONZ
-35.04%
$2.21
NVTS
+23.51%
$10.16
JOBY
+2.94%
$16.76
ETHD
+16.10%
$3.82
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
SNAP
-7.15%
$7.78
QBTS
+23.97%
$40.93
INTC
+2.03%
$37.11
GPUS
-12.50%
$0.41
WULF
-0.58%
$13.51
F
+1.27%
$11.55
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
CLF
+4.66%
$13.79
TSLA
+5.01%
$434.23
QS
+16.36%
$17.10
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
RR
-9.34%
$5.92
TLRY
-1.74%
$1.69
ACHR
+6.09%
$12.70
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
NAK
+29.80%
$2.63
SOUN
+10.25%
$19.14
RXRX
+4.41%
$5.55
ONDS
+17.24%
$10.81
CIFR
+19.77%
$20.32
MP
+21.94%
$95.52
LAES
+13.49%
$6.14
APLD
+2.14%
$34.71
BTBT
+5.58%
$3.97
VALE
-2.53%
$10.75
SOFI
+4.45%
$27.35
DVLT
-12.36%
$1.66
USAR
+17.01%
$38.15
IREN
+7.31%
$64.14
DFLI
+41.35%
$1.54
PFE
-0.30%
$24.70
WBD
-3.22%
$17.10
QUBT
+12.85%
$21.46
ABAT
+33.25%
$8.99
UUUU
+16.88%
$23.77
UAMY
+35.91%
$16.59
RMBL
+60.50%
$3.21
EOSE
+23.62%
$17.08
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
CORZ
+2.66%
$18.52
XCH
+103.41%
$1.68
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
MARA
+9.43%
$20.40
TMQ
-9.46%
$5.93
NAKA
-4.05%
$0.83
BULL
+2.98%
$11.74
PLTR
+0.84%
$176.92
SRM
+53.27%
$10.30
NOK
-1.79%
$5.22
IONQ
+18.72%
$83.88
RF
+1.75%
$24.58
BMNR
+7.40%
$56.35
GDXD
-12.99%
$0.74
T
-1.06%
$25.59
QSI
+26.28%
$2.10
CLSK
+2.49%
$19.76
SMR
+14.72%
$45.02
BINI
-55.00%
$0.63
MULN
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ABEV
+1.18%
$2.13
NEHC
-8.12%
$2.60
WLGS
-5.57%
$0.04
BE
+26.54%
$109.93
BTG
+3.87%
$5.27
RGTZ
-50.00%
$9.30
WWR
0.00%
$1.98
TMC
+20.31%
$10.69
KDLY
-7.21%
$0.87
AMC
+0.68%
$2.95
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
VHAI
-25.00%
$0.00
YYAI
-12.69%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+6.25%
$0.50
PLUG
+13.30%
$3.87
ELBM
+334.95%
$7.17
GWH
+118.14%
$9.07
BITF
+28.33%
$5.39
RGTI
+20.26%
$52.82
NVDA
+2.98%
$188.62
ASST
-35.33%
$1.00
BYND
-48.50%
$1.03
IONZ
-35.04%
$2.21
NVTS
+23.51%
$10.16
JOBY
+2.94%
$16.76
ETHD
+16.10%
$3.82
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
SNAP
-7.15%
$7.78
QBTS
+23.97%
$40.93
INTC
+2.03%
$37.11
GPUS
-12.50%
$0.41
WULF
-0.58%
$13.51
F
+1.27%
$11.55
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
CLF
+4.66%
$13.79
TSLA
+5.01%
$434.23
QS
+16.36%
$17.10
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
RR
-9.34%
$5.92
TLRY
-1.74%
$1.69
ACHR
+6.09%
$12.70
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
NAK
+29.80%
$2.63
SOUN
+10.25%
$19.14
RXRX
+4.41%
$5.55
ONDS
+17.24%
$10.81
CIFR
+19.77%
$20.32
MP
+21.94%
$95.52
LAES
+13.49%
$6.14
APLD
+2.14%
$34.71
BTBT
+5.58%
$3.97
VALE
-2.53%
$10.75
SOFI
+4.45%
$27.35
DVLT
-12.36%
$1.66
USAR
+17.01%
$38.15
IREN
+7.31%
$64.14
DFLI
+41.35%
$1.54
PFE
-0.30%
$24.70
WBD
-3.22%
$17.10
QUBT
+12.85%
$21.46
ABAT
+33.25%
$8.99
UUUU
+16.88%
$23.77
UAMY
+35.91%
$16.59
RMBL
+60.50%
$3.21
EOSE
+23.62%
$17.08
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
CORZ
+2.66%
$18.52
XCH
+103.41%
$1.68
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
MARA
+9.43%
$20.40
TMQ
-9.46%
$5.93
NAKA
-4.05%
$0.83
BULL
+2.98%
$11.74
PLTR
+0.84%
$176.92
SRM
+53.27%
$10.30
NOK
-1.79%
$5.22
IONQ
+18.72%
$83.88
RF
+1.75%
$24.58
BMNR
+7.40%
$56.35
GDXD
-12.99%
$0.74
T
-1.06%
$25.59
QSI
+26.28%
$2.10
CLSK
+2.49%
$19.76
SMR
+14.72%
$45.02
BINI
-55.00%
$0.63
MULN
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ABEV
+1.18%
$2.13
NEHC
-8.12%
$2.60
WLGS
-5.57%
$0.04
BE
+26.54%
$109.93
BTG
+3.87%
$5.27
RGTZ
-50.00%
$9.30
WWR
0.00%
$1.98
TMC
+20.31%
$10.69
KDLY
-7.21%
$0.87
AMC
+0.68%
$2.95
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.